Stroma Biosciences

WHAT’S NEW

Stroma Biosciences has made the #21toWatch Companies Longlist

by | Dec 15, 2022 | Media coverage, No category

Stroma Biosciences is delighted to announce that it has made the #21toWatch Companies longlist. 

The highly respected annual #21toWatch campaign and awards programme showcases the people, companies and ‘things’ that are setting the standards of innovation and entrepreneurship across the Eastern region.

We are proud to have been included in the #21toWatch longlist alongside a host of innovative companies.

LATEST NEWS

Stroma Biosciences Announces Appointment of New Chairman

Stroma Biosciences Announces Appointment of New Chairman

Stroma Biosciences, Ltd, a Cambridge based oncology company today announced the appointment of Dr John Beadle as Executive Chairman. Dr Beadle, who previously held the role of CEO at PsiOxus Therapeutics, joins the Stroma Board at a critical time for growth of the...

read more
Seed funding investment

Seed funding investment

We are delighted to have raised seed funding investment from Start Codon. The funding will support the development of our research platform and generation of data for our novel targets. Start Codon link: Startcodon.co

read more
Science Translational medicine Cover

Science Translational medicine Cover

Stroma Biosciences co-founders have been accepted as the cover story in Science Translational Medicine for their work on the tumour microenvironment. The research found that treating the normal cells near to the cancer cells with small molecule inhibitors...

read more